Propylene Glycol

Propylene Glycol

SCHEMBL358822

CC(=O)O.CC(=O)O.CC(=O)O.CC(O)CO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.67
FFAR3 O14843 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
OR51E2 Q9H255 1/20 0.45
TP53 P04637 1/20 0.44
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.38
AKR1B1 P15121 1/20 0.38
PDE4A P27815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylene Glycol SCHEMBL28241687 1.00 TDP1 (0.67) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL8850998 1.00 TDP1 (0.67) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL21828462 1.00 TDP1 (0.67) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL49092 1.00 TDP1 (0.67) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL36041 1.00
Propylene Glycol SCHEMBL27725301 0.97 TDP1 (0.62) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL5153430 0.97 TDP1 (0.62) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL27695057 0.97 TDP1 (0.62) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL28810431 0.94 TDP1 (0.59) TDP1FFAR3LCKFYNOR51E2
Propylene Glycol SCHEMBL11062962 0.94 TDP1 (0.59) TDP1FFAR3LCKFYNOR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102395388-B Production of moldable bone substitutes PROMIMIC AB (SE) 2016-03-09 CN claimed
US-20130266643-A1 Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis HPO LIFE SCIENCES INC (US) 2013-10-10 US claimed
CN-102395388-A Production of moldable bone substitutes PROMIMIC AB 2012-03-28 CN claimed
EP-0092993-B1 COMPOSITION FOR INVESTIGATING ALIMENTARY FUNCTIONS A/S Alfred Benzon (DK) 1989-03-01 EP claimed
WO-1983003762-A1 COMPOSITION AND METHOD FOR INVESTIGATING ALIMENTARY FUNCTIONS A/S ALFRED BENZON (DK) 1983-11-10 WO claimed
EP-0092993-A2 Composition for investigating alimentary functions A/S Alfred Benzon (DK) 1983-11-02 EP claimed
CN-118369306-A Enol ether pro-fragrances 弗门尼舍有限公司 2024-07-19 CN disclosed
CN-118302402-A Process for the preparation of cyclic dienes 弗门尼舍有限公司 2024-07-05 CN disclosed
CN-118251207-A Fragrance composition with moisturizing benefit 弗门尼舍有限公司 2024-06-25 CN disclosed
CN-118215656-A Cyclic acetals and ketals for photoinduction-released active aldehydes and ketones 弗门尼舍有限公司 2024-06-18 CN disclosed
CN-113873884-B Arthropod control composition 弗门尼舍有限公司 2024-06-14 CN disclosed
CN-114794101-B Antimicrobial compositions 弗门尼舍有限公司 2024-06-14 CN disclosed
CN-111183136-B Amber odorant 弗门尼舍有限公司 2024-05-28 CN disclosed
WO-2006089843-A2 ANTI-MISUSE MICROPARTICULATE ORAL DRUG FORM FLAMEL TECHNOLOGIES (FR) 2006-08-31 WO disclosed
WO-2006087395-A1 MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM WITH MODIFIED RELEASE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS FLAMEL TECHNOLOGIES (FR) 2006-08-24 WO disclosed
WO-2006087394-A1 ORAL PHARMACEUTICAL FOR OF LOSARTAN FLAMEL TECHNOLOGIES (FR) 2006-08-24 WO disclosed
US-6235312-B1 MONOGLYCERIDES WITH ACYL GROUPS WITH WATER EASTMAN CHEMICAL COMPANY 2001-05-22 US disclosed
EP-0266199-B2 Liquid cleaning products UNILEVER PLC (GB) 2000-02-09 EP disclosed
CN-1048861-A What contain disordered structure starch is the blend compositions of base-material with the polymkeric substance WARNER LAMBERT CO (US) 1991-01-30 CN disclosed
EP-0092993-B1 COMPOSITION FOR INVESTIGATING ALIMENTARY FUNCTIONS A/S Alfred Benzon (DK) 1989-03-01 EP disclosed